Management of Nasal Bleeding in an 80-Year-Old Male on Eliquis with History of Stroke
For an 80-year-old male on apixaban (Eliquis) with history of stroke presenting with nasal bleeding to the ED, first-line treatment should include firm sustained compression to the lower third of the nose for 10-15 minutes, followed by topical vasoconstrictors, while maintaining anticoagulation unless bleeding is life-threatening.
Initial Assessment and Management
Apply firm sustained compression:
- Apply firm pressure to the lower third of the nose (anterior nares) for 10-15 minutes 1
- This simple technique has high success rates when performed correctly
- Patient should be sitting upright, leaning slightly forward to prevent blood from flowing down the throat
Identify bleeding site:
- After compression, perform anterior rhinoscopy to identify the source of bleeding 2
- Remove any blood clots gently to improve visualization
- If anterior rhinoscopy is insufficient, nasal endoscopy should be performed to identify posterior bleeding sites
Apply topical vasoconstrictors:
- Use oxymetazoline or phenylephrine-soaked cotton pledgets to the bleeding site 1
- Success rate of 65-75% for controlling epistaxis
- Apply for 5-10 minutes
Anticoagulation Management
Important: In the absence of life-threatening bleeding, do NOT reverse or discontinue anticoagulation 2, 1
- Continue apixaban therapy as the risk of thrombotic events (especially with history of stroke) outweighs the risk of continued nasal bleeding
- Premature discontinuation of apixaban increases the risk of thrombotic events 3
- First-line treatments should be initiated prior to considering any changes to anticoagulation 2
Advanced Management Options
If bleeding persists despite initial measures:
Topical tranexamic acid:
- Apply via cotton pledgets soaked with TXA solution to the bleeding site 1
- Particularly effective in patients on antiplatelet or anticoagulant medications
Nasal cautery:
Nasal packing:
Special Considerations for This Patient
- Age and anticoagulation: At 80 years, this patient is at higher risk for both bleeding complications and stroke recurrence
- History of stroke: This significantly increases the importance of maintaining anticoagulation 4
- Recent evidence shows patients with history of stroke and atrial fibrillation have a 7% absolute risk reduction in stroke or systemic embolism over 3.5 years with apixaban compared to aspirin 4
- Avoid nasal trauma: Educate patient to avoid digital trauma (nose picking), vigorous nose blowing, and to use nasal moisturization with saline gel/spray 1-3 times daily to prevent recurrence 1
When to Consider More Aggressive Intervention
Escalate care if:
- Bleeding cannot be controlled with the above measures
- Signs of hemodynamic instability develop
- Bilateral bleeding or bleeding from posterior sites
- Bleeding duration >30 minutes despite compression 2
Discharge Planning and Prevention
Nasal moisturization:
- Recommend saline gel or spray 1-3 times daily 1
- Consider home humidification in dry environments
Patient education:
- Proper technique for nasal compression if bleeding recurs
- Avoid digital trauma and vigorous nose blowing
- Warning signs requiring return to ED (recurrent heavy bleeding, swallowing large amounts of blood)
Follow-up:
- Document outcome within 30 days or ensure transition of care 2
- Consider ENT referral if recurrent episodes occur
This approach prioritizes both bleeding control and stroke prevention in this high-risk patient, recognizing that maintaining anticoagulation is crucial for preventing potentially devastating thromboembolic events in a patient with prior stroke history.